Zopiclone
Brand names: Zimovane
Zopiclone is a short-acting cyclopyrrolone hypnotic used for the short-term management of insomnia.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It enhances GABAergic inhibitory transmission by acting at the benzodiazepine binding site of the GABA-A receptor complex.
Prescribing in practice
- Tolerance and dependence can develop, so it should be limited to short-term use at the lowest effective dose.
- Next-day drowsiness can impair driving and skilled tasks, particularly in older people who are also more prone to falls.
- A characteristic bitter or metallic taste is common and may affect adherence.
Monitoring
Review continued need regularly and monitor for dependence, daytime sedation and falls risk in older patients.
Counselling the patient
- You may notice a bitter or metallic taste, which is harmless.
- Avoid alcohol and do not drive if you feel drowsy the next day.
- Use it for as short a time as possible to avoid becoming dependent.
Evidence & guidelines
NICE advises that hypnotics such as Z-drugs be used only for severe insomnia and for the shortest period possible.
Reference: NICE NG215 Insomnia; MHRA Drug Safety Update 2022; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185